Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-26

Clinical Trial Update: A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation [Phase 4]

View source ↗

Summary

This Phase 4 trial compares the safety and efficacy of Cetrotide 3 mg versus Antagon in women undergoing ovarian stimulation for assisted reproductive technolog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antagon (ganirelix)
  • CETROTIDE (cetrorelix acetate)

Snippet

Sponsor: EMD Serono | Conditions: Infertile Women Undergoing Assisted Reproductive Technology (ART) | Phase 4 | Status: COMPLETED